White House is reviewing CBD and marijuana research guidance from FDA

White House is reviewing CBD and marijuana research guidance from FDA

Details about the document titled Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research are sparse. But an FDA spokesperson indicated to Marijuana Moment that its rela…
Read More

Leave a Reply

Your email address will not be published. Required fields are marked *